Adolescents Show High Tolerance on Pfizer-BioNTech COVID-19 Vaccine, 100-Percent Efficacy Medicine & Technology Mar 31, 2021 Pfizer announced that the Pfizer-BioNTech COVID-19 vaccine showed a 100-percent efficacy and is well-tolerated in younger people whose ages range between 12 and 15 years.
TECH & INNOVATION OpenAI’s Whisper Faces Scrutiny Over Accuracy, Experts Find 'Hallucinated' Text in Transcripts